Apomab, a fully human agonistic DR5 monoclonal antibody...

Bone 2009 Vol. 44; Iss. supp-S1

Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression

I. Zinonos, A. Labrinidis, V. Liapis, S. Hay, M. Lee, V. Ponomarev, P. Diamond, A.C.W. Zannettino, D.M. Findlay, A. Evdokiou
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
44
Year:
2009
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2009.01.463
File:
PDF, 62 KB
english, 2009
Conversion to is in progress
Conversion to is failed